Combination of NTP with cetuximab inhibited invasion/migration of cetuximab-resistant OSCC cells: Involvement of NF-κB signaling
Open Access
- 14 December 2015
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 18208
Abstract
Although the epidermal growth factor receptor (EGFR) is an established target in head-and-neck cancer (HNC), resistance to EGFR-targeted therapy mediated by various mechanisms has been reported. Therefore, a combination strategy to overcome resistance to EGFR mono-targeted therapy is clinically required. We have previously demonstrated that non-thermal atmospheric pressure plasma (NTP) induces death of various cancer cells, including oral squamous cancer (OSCC) cells. In this study, we report for the first time that combining NTP treatment with cetuximab led to inhibition of migration and invasion in cetuximab-resistant OSCC cells, which could be a promising strategy to overcome resistance to anti-EGFR therapy. NTP induced deactivation of NF-κB in SCCQLL1 cells, but not in MSKQLL1 cells. In addition, NTP increased the expression level of E-cadherin and decreased those of vimentin, Slug, Snail, matrix metalloproteinase (MMP)-2, -9 and activities of MMPs. Moreover, NF-κB upregulation using cDNA diminished the combination effect of NTP on invasion, migration and related signals. Taken together, these results indicate that the combination of NTP with cetuximab can decrease invasiveness in cetuximab-resistant OSCCs through a novel mechanism involving the NF-κB pathway. These findings show the therapeutic potential of treatment that combines NTP and cetuximab in OSCC.Keywords
This publication has 39 references indexed in Scilit:
- Anti-Cancer Activity of a Novel Small Molecule Compound That Simultaneously Activates p53 and Inhibits NF-κB SignalingPLOS ONE, 2012
- Epithelial–Mesenchymal Transition Induced by TNF-α Requires NF-κB–Mediated Transcriptional Upregulation of Twist1Cancer Research, 2012
- Atmospheric-Pressure Plasma Jet Induces Apoptosis Involving Mitochondria via Generation of Free RadicalsPLOS ONE, 2011
- Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy ResistanceCancer Discovery, 2011
- Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cellsApplied Physics Letters, 2010
- RETRACTED: Theaflavins retard human breast cancer cell migration by inhibiting NF‐κB via p53‐ROS cross‐talkFEBS Letters, 2009
- Targeting EGFR resistance networks in head and neck cancerCellular Signalling, 2009
- Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell CarcinomaCancer Research, 2006
- Reactive Oxygen Species-induced Phosphorylation of p53 on Serine 20 Is Mediated in Part by Polo-like Kinase-3Journal of Biological Chemistry, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000